Medicare Enrolled
Dr. Jose David, M.D.
Addiction Medicine (Family Medicine) Physician · Albany, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. David from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. David?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. David
Dr. Jose David is an addiction medicine physician in Albany, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. David performed 1,928 Medicare services across 923 unique beneficiaries.
Between the years covered by Open Payments, Dr. David received a total of $89,801 from 84 pharmaceutical and/or device companies across 1616 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in addiction medicine (family medicine) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. David is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 7% volume in NY
$89,801 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,928
Medicare services
Top 7% in NY for addiction medicine (family medicine) physician
923
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~96 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
829 | $77 | $190 |
| Home visit, established patient, high complexity A home visit for an established patient involving high-level medical decision making, lasting at least 60 minutes. |
279 | $126 | $265 |
| Home visit, established patient, moderate complexity A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service. |
207 | $77 | $190 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
89 | $30 | $40 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
75 | $27 | $87 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
72 | $69 | $70 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
69 | $8 | $45 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
58 | $117 | $265 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
54 | $58 | $135 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
50 | $117 | $195 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
34 | $3 | $10 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
28 | $10 | $50 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
16 | $33 | $45 |
| Home visit, new patient, high complexity A home visit for a new patient involving high-level medical decision making, lasting at least 75 minutes. |
16 | $147 | $295 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
15 | $42 | $75 |
| Home visit, established patient, low complexity A physician visits an existing patient at their residence to provide care involving a low level of medical decision making. The visit lasts at least 30 minutes. |
13 | $17 | $125 |
| Annual depression screening | 13 | $12 | $12 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
11 | $31 | $65 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$89,801
Total received (2018-2024)
Avg $12,829/year across 7 years
Top 3% in NY for addiction medicine (family medicine) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
84
Companies
1,616
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$63,512 (70.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,104 (26.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,185 (2.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$21,527
2023
$27,554
2022
$13,645
2021
$13,884
2020
$7,738
2019
$2,355
2018
$3,098
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$11,095
ABBVIE INC.
$3,354
SANOFI-AVENTIS U.S. LLC
$2,185
AstraZeneca Pharmaceuticals LP
$859
Axsome Therapeutics, Inc.
$424
Gilead Sciences, Inc.
$364
Vanda Pharmaceuticals Inc.
$299
Braeburn Inc.
$277
Amgen Inc.
$255
Bayer Healthcare Pharmaceuticals Inc.
$168
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$166
Neurocrine Biosciences, Inc.
$160
Esperion Therapeutics, Inc.
$158
Novo Nordisk Inc
$154
Otsuka America Pharmaceutical, Inc.
$149
Astellas Pharma US Inc
$147
PFIZER INC.
$134
GlaxoSmithKline, LLC.
$131
Alkermes, Inc.
$91
Lundbeck LLC
$90
Alnylam Pharmaceuticals Inc.
$84
Indivior Inc.
$80
Orexo US, Inc.
$75
Exact Sciences Corporation
$62
Paratek Pharmaceuticals, Inc.
$62
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$61
Renalytix AI, Inc.
$57
Novartis Pharmaceuticals Corporation
$54
Lilly USA, LLC
$40
Abbott Laboratories
$37
Collegium Pharmaceutical, Inc.
$36
UCB, Inc.
$36
Takeda Pharmaceuticals U.S.A., Inc.
$34
Teva Pharmaceuticals USA, Inc.
$25
Eisai Inc.
$23
IDORSIA PHARMACEUTICALS US INC
$23
SHIELD THERAPEUTICS INC
$21
E.R. Squibb & Sons, L.L.C.
$17
Optinose US, Inc.
$15
Dexcom, Inc.
$14
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Top 3 companies account for 77.3% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$20,340
AbbVie Inc.
$16,001
IDORSIA PHARMACEUTICALS US INC
$11,112
ABBVIE INC.
$10,354
Allergan, Inc.
$6,455
SANOFI-AVENTIS U.S. LLC
$2,361
AstraZeneca Pharmaceuticals LP
$2,024
Novo Nordisk Inc
$1,864
Amgen Inc.
$1,317
Allergan Inc.
$1,029
Lilly USA, LLC
$1,008
Gilead Sciences, Inc.
$953
Astellas Pharma US Inc
$941
PFIZER INC.
$929
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$790
GlaxoSmithKline, LLC.
$721
Axsome Therapeutics, Inc.
$661
Esperion Therapeutics, Inc.
$630
Neurocrine Biosciences, Inc.
$506
Abbott Laboratories
$457
ITI, Inc.
$429
Indivior Inc.
$424
Bayer HealthCare Pharmaceuticals Inc.
$381
Orexo US, Inc.
$372
Teva Pharmaceuticals USA, Inc.
$368
Braeburn Inc.
$344
Bayer Healthcare Pharmaceuticals Inc.
$337
Sunovion Pharmaceuticals Inc.
$309
Renalytix AI, Inc.
$303
Novartis Pharmaceuticals Corporation
$303
Vanda Pharmaceuticals Inc.
$299
Alnylam Pharmaceuticals Inc.
$289
Boehringer Ingelheim Pharmaceuticals, Inc.
$283
Otsuka America Pharmaceutical, Inc.
$268
Kowa Pharmaceuticals America, Inc.
$262
Takeda Pharmaceuticals U.S.A., Inc.
$254
Collegium Pharmaceutical, Inc.
$251
Galderma Laboratories, L.P.
$243
Merck Sharp & Dohme Corporation
$232
Avanir Pharmaceuticals, Inc.
$218
Eisai Inc.
$207
Merck Sharp & Dohme LLC
$192
Daiichi Sankyo Inc.
$187
Alkermes, Inc.
$187
Biohaven Pharmaceuticals, Inc.
$182
Exact Sciences Corporation
$146
IBSA Pharma Inc.
$146
Lundbeck LLC
$143
Biohaven Pharmaceutical Holding Company Ltd.
$137
Nestle HealthCare Nutrition Inc.
$116
UROVANT SCIENCES INC
$102
Endo Pharmaceuticals Inc.
$96
Sumitomo Pharma America, Inc.
$93
E.R. Squibb & Sons, L.L.C.
$86
Dexcom, Inc.
$85
Bausch Health US, LLC
$84
Biogen, Inc.
$83
Paratek Pharmaceuticals, Inc.
$82
Arbor Pharmaceuticals, Inc.
$70
Regeneron Healthcare Solutions, Inc.
$66
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$61
UCB, Inc.
$61
Seqirus USA Inc
$53
Nabriva Therapeutics, plc
$45
RedHill Biopharma Inc.
$44
Ironwood Pharmaceuticals, Inc
$41
JAZZ PHARMACEUTICALS INC.
$41
Amarin Pharma Inc.
$38
Medtronic, Inc.
$34
Scilex Pharmaceuticals Inc.
$33
Radius Health, Inc.
$29
SHIELD THERAPEUTICS INC
$21
IRONWOOD PHARMACEUTICALS, INC
$21
Corcept Therapeutics
$19
Shield Therapeutics Inc
$18
ARBOR PHARMACEUTICALS, INC.
$17
Almatica Pharma LLC
$17
Shionogi Inc
$15
DEXCOM, INC.
$15
Optinose US, Inc.
$15
AbbVie, Inc.
$15
Acorda Therapeutics, Inc
$13
SCILEX PHARMACEUTICALS INC.
$13
BioDelivery Sciences International, Inc.
$12
Top 3 companies account for 52.8% of all-time payments
Associated products mentioned in payments ›
ABILIFY MYCITE · ACCRUFER · ADUHELM · AIRSUPRA · AJOVY · AKLIEF · APTIOM · AREXVY · ARISTADA · AUSTEDO · Aemcolo · Aimovig · AirDuo Digihaler · Austedo XR · Auvelity · BAQSIMI · BELSOMRA · BREZTRI · BREZTRI AEROSPHERE · BRIXADI · BUNAVAIL 2.1 mg 30-count box · BYSTOLIC · Belbuca · CAMZYOS · CAPLYTA · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CREON · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · Dayvigo · Descovy · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · EVKEEZA · Edarbi · Epclusa · FANAPT · FARXIGA · FLUCELVAX QUADRIVALENT · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Fluad · FreeStyle Libre · FreeStyle Libre 2 · GEMTESA · GIVLAARI · HUMIRA · Horizant · INBRIJA · INGREZZA · INJECTAFER · INPEN SMART INSULIN DELIVERY SYSTEM · INVEGA SUSTENNA · INVOKANA · JANUVIA · JARDIANCE · JYNARQUE · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · Kerendia · Korlym · LEQVIO · LINZESS · LOKELMA · LONHALA MAGNAIR · LOREEV XR · LUCEMYRA · LYBALVI · LYRICA · Leqembi · Linzess · Livalo · MAVYRET · MOUNJARO · MYRBETRIQ · Movantik · Myrbetriq · NASCOBAL · NEXLETOL · NEXLIZET · NUEDEXTA · NURTEC ODT · NUZYRA · Nayzilam · Nuedexta · ORIAHNN · Otezla · Ozempic · PAXLOVID · PRALUENT ALIROCUMAB INJECTION · Prolia · QULIPTA · QUVIVIQ · RELISTOR · REXULTI · RYBELSUS · Repatha · Rybelsus · SEEBRI · SEGLENTIS · SHINGRIX · SOLIQUA 100/33 · SPINRAZA · SPRAVATO · STEGLATRO · STIOLTO RESPIMAT · SUBLOCADE · SUNOSI · SYMBICORT · SYNTHROID · Saxenda · Seglentis · Spectra · Symproic · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · TWYNEO · TZIELD · Tirosint · Tresiba · Trintellix · Tymlos · UBRELVY · UTIBRON · Utibron · VERQUVO · VESICARE · VIAGRA · VIBERZI · VIIBRYD · VIVITROL · VRAYLAR · Vascepa · Veozah · Victoza · Vivitrol · Vivitrol 380 mg · WELLBUTRIN · Wegovy · XARELTO · XIFAXAN · XTAMPZA · XTAMPZAER · Xenleta · Xhance · Xtampza ER · ZENPEP · ZEPBOUND · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (71%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in addiction medicine (family medicine) physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for addiction medicine (family medicine) physician in NY.
Geographic Context
Addiction medicine physicians within 10 mi
3
Per 100K population
1.0
County median income
$83,149
Nearest hospital
ALBANY MEDICAL CENTER HOSPITAL
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. David is a clinical cardiology specialist, with above-average Medicare volume (top 7% in NY), with speaking/promotional industry engagement in the top 3% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. David experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. David performed 829 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. David receive payments from pharmaceutical companies?
Yes. Dr. David received a total of $89,801 from 84 companies across 1,616 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. David's costs compare to other addiction medicine physicians in Albany?
Dr. David's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. David) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Addiction Medicine Physicians in Albany
Browse addiction medicine physicians in Albany ranked by procedure volume and transparency data.
Highest volume
Top Addiction Medicine Physicians in NY
Addiction medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Addiction Medicine Physicians in NY
Which NY addiction medicine physicians receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
IDORSIA PHARMACEUTICALS US INC Payments to Doctors
See all physicians who received payments from IDORSIA PHARMACEUTICALS US INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology